MyFinsight
Home
Blog
About
Marketable securities
$302,290K
(143.47%↑ Y/Y)
Cash and cash
equivalents
$217,706K
(51.32%↑ Y/Y)
Prepaid expenses and
other current assets
$18,453K
(96.39%↑ Y/Y)
Total current assets
$538,449K
(94.08%↑ Y/Y)
Property and equipment,
net
$17,359K
(57.45%↑ Y/Y)
Other long-term
assets
$5,424K
(24.58%↑ Y/Y)
Operating right-of-use
assets
$3,942K
(20.59%↑ Y/Y)
Restricted cash
$210K
(0.00%↑ Y/Y)
Total assets
$565,384K
(90.82%↑ Y/Y)
Total liabilities and
stockholders' equity
$565,384K
(90.82%↑ Y/Y)
Total stockholders'
equity
$525,083K
(95.00%↑ Y/Y)
Total liabilities
$40,301K
(49.15%↑ Y/Y)
Accumulated deficit
-$855,130K
(-42.33%↓ Y/Y)
Accumulated other
comprehensive loss
-$333K
(-1287.50%↓ Y/Y)
Additional paid-in capital
$1,380,535K
(58.67%↑ Y/Y)
Total current
liabilities
$35,713K
(56.10%↑ Y/Y)
Operating lease
liabilities, net of current...
$4,588K
(10.77%↑ Y/Y)
Common stock, 0.0001
par value...
$11K
(22.22%↑ Y/Y)
Accrued expenses and
other current...
$29,717K
(63.12%↑ Y/Y)
Accounts payable
$5,996K
(28.67%↑ Y/Y)
Back
Back
Balance Sheet
Immunome Inc. (IMNM)
Immunome Inc. (IMNM)
source: myfinsight.com